Finch Therapeutics Group, Inc. Quarterly Current Ratio in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Finch Therapeutics Group, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2024.
  • Finch Therapeutics Group, Inc. Current Ratio for the quarter ending June 30, 2024 was 557 %, a 16.5% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 557 +78.8 +16.5% Jun 30, 2024
Q1 2024 515 -46.2 -8.23% Mar 31, 2024
Q4 2023 427 -231 -35.1% Dec 31, 2023
Q3 2023 435 -335 -43.5% Sep 30, 2023
Q2 2023 478 -479 -50% Jun 30, 2023
Q1 2023 561 -637 -53.2% Mar 31, 2023
Q4 2022 659 -850 -56.3% Dec 31, 2022
Q3 2022 770 -772 -50.1% Sep 30, 2022
Q2 2022 956 Jun 30, 2022
Q1 2022 1.2K Mar 31, 2022
Q4 2021 1.51K Dec 31, 2021
Q3 2021 1.54K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.